Connecta Therapeutics, S.L.
3 clinical trials · Sponsor
◉ Watch Connecta Therapeutics, S.L.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome (NCT07654114) | Connecta Therapeutics, S.L. | 2026-05-21 |
| Neural Biomarkers in Fragile X Syndrome (NCT06957054) | Connecta Therapeutics, S.L. | 2024-12-16 |
| CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction (NCT06480968) | Connecta Therapeutics, S.L. | 2023-06-23 |
Track Connecta Therapeutics, S.L. automatically
Every clearance here is in the API, with alerts when new ones post.